Content

Other institutions

Global Fund to Fight AIDS, Tuberculosis and Malaria

Logo: Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM)

AIDS, tuberculosis and malaria are among the most widespread infectious diseases worldwide. The objective to eradicate these global epidemics by 2030 was adopted in September 2015 as Goal 3.3 of the 2030 Agenda for Sustainable Development.

One important instrument in the efforts to achieve this goal is the Global Fund to Fight AIDS, Tuberculosis and Malaria (known as the "Global Fund" for short). The decision to set up this fund was taken at the UN General Assembly Special Session on HIV and AIDS in New York in June 2001. The Fund does not implement its own programmes, it funds national actions to fight the three diseases, thereby promoting government ownership. It also fosters civil society and private sector involvement.

By April 2020, the Global Fund had made a total of 44.5 billion US dollars available worldwide. In autumn 2019, the sixth replenishment conference was held for the Global Fund. At the conference, donors pledged 14 billion US dollars for the period from 2020 to 2022.

Four billion dollars of this amount is to be used to build resilient health systems, which are the basis for successfully fighting HIV, tuberculosis and malaria.

In the current COVID-19 pandemic, the Global Fund will provide up to one billion US dollars to support the efforts of its partner countries to respond to the pandemic. This will enable them, for instance, to provide protective gear to health personnel, carry out training programmes and finance diagnostic testing.


Impacts

According to the Global Fund, notable successes were achieved in the period between 2002 and 2018: the programmes supported by the Global Fund helped to save some 32 million lives. By the end of 2022, that number is to increase to 48 million. In the countries where the Global Fund has provided support, the number of deaths from AIDS, tuberculosis or malaria has declined by 40 per cent since 2002.

According to the Results Report 2019, nearly 19 million people living with HIV had access to antiretroviral therapy in 2018. The share of people living with HIV who have access to such therapy worldwide increased from 22 per cent in 2010 to 62 per cent in 2018.

5.3 million people suffering from tuberculosis received treatment in 2018 with support from the Global Fund. And some 131 million bed nets were distributed during that year to prevent malaria. Since 2000, the number of deaths from malaria has fallen by 46 per cent.


German contribution

Germany has committed more than 3 billion euros (as at March 2020) to the Fund since it was set up in 2002.

With a total contribution of one billion euros for the period from 2020 to 2022, Germany is the Fund's fourth-largest public donor. Since September 2012, Germany has had its own seat on the Board of the Fund.

And Germany is part of the Strategy Committee, where it is working for an efficient, effective Global Fund and helping to draft the Fund's new strategy for the post-2022 period.

Germany's involvement focuses on areas such as strengthening national health systems, involving civil society and stakeholder self-help groups, and promoting gender equality and human rights. Germany aims to create synergies with other organisations, such as Gavi, the Vaccine Alliance. Germany is particularly committed to ensuring that Global Fund investments are sustainable and have a long-term impact even once the funding has ended.


More information

Contact

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Chemin de Blandonnet 8
1214 Vernier

Switzerland
Phone: +41 / 22 / 7 91 17 00
Fax: +41 / 22 / 7 91 17 01

BMZ glossary

Close window

 

Share page